No. of Pages: 184 | Report Code: BMIRE00028604 | Category: Life Sciences
核医学治疗诊断学聚集了研究人员的研究成果通过分子成像和个性化医疗产生兴趣。这是通过协助管理各种疾病、改进患者选择过程、预测药物反应和毒性、确定预后以及帮助避免徒劳且昂贵的检查和治疗来实现的。核医学的治疗诊断方法涉及诊断成像和基于放射性药物的治疗的结合。它的主要重点是诊断，而次要重点是肿瘤部位的治疗。放射性碘是第一种用于甲状腺疾病治疗和成像的治疗诊断放射性药物。在放射性碘治疗中，放射性同位素碘131是γ和β发射体，碘化钠同向转运体可以直接将γ发射体介导至甲状腺细胞。此外，伽马和正电子发射器(β+)用于核成像。 SPECT 成像中使用锝-99m 或碘-123 等伽马发射器，而在 PET 成像中使用镓-68 和氟-18 可以提供更好的分辨率。因此，基于治疗诊断的核靶向治疗正在成为治疗患有晚期神经内分泌和胃肠胰腺肿瘤（如神经母细胞瘤）的患者的有用工具。
亚太地区放射性药物治疗诊断市场分为中国、日本、印度、韩国、澳大利亚和亚太其他地区。中国在 2021 年占据最大的市场份额，印度预计在预测期内将呈现显着的市场增长速度。这些国家的市场增长归因于慢性病患病率的上升和有利的报销政策。此外，市场参与者实施的扩张和产品推出策略预计将有助于该地区放射性药物治疗市场的增长。
< strong>亚太地区放射性药物治疗市场细分
亚太地区放射性药物治疗市场细分为产品类型、放射性同位素、来源、应用、适应症、最终用户、和国家。根据产品类型，亚太地区放射性药物治疗诊断市场分为α发射器、β发射器和正电子发射断层扫描（PET）示踪剂。 PET示踪剂细分市场在2022年占据最大的市场份额。
根据放射性同位素，亚太地区放射性药物治疗市场分为锝-99、镓-68、碘-131 、碘 123、氟 18 (18F)、钇 90 (Y-90)、镥 (Lu) 177、铜 (Cu) 67、铜 (Cu) 64 等。镥 (Lu) 177 细分市场在 2022 年占据最大的市场份额。
根据消息来源，亚太放射性药物治疗市场分为核反应堆和回旋加速器。到2022年，回旋加速器细分市场将占据更大的市场份额。
根据应用，亚太放射性药物治疗市场分为靶向治疗（Rx）和伴随诊断（CDx）。到2022年，靶向治疗（Rx）细分市场将占据更大的市场份额。
根据适应症，亚太放射性药物治疗市场分为肿瘤学、心脏病学、神经学等。肿瘤学领域在 2022 年占据最大的市场份额。
根据最终用户，亚太放射性药物治疗市场分为医院、诊断成像中心、学术和研究机构、和别的。 2022 年，肿瘤学领域占据最大的市场份额。
按国家/地区划分，亚太地区放射性药物治疗市场分为中国、印度、日本、澳大利亚、韩国和亚太地区其他地区。 2022 年，中国在亚太放射性药物治疗市场份额中占据主导地位。
拜耳公司、GE 医疗保健技术公司、Curium、Telix Pharmaceuticals Ltd 和 Cardinal Health Inc. 均位列其中。亚太放射性药物治疗诊断市场的领先公司。
Strategic insights for Asia Pacific Radiopharmaceutical Theranostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 337.53 Million |
| Market Size by 2028 | US$ 667.40 Million |
| Global CAGR (2022 - 2028) | 12.0% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 产品类型
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Radiopharmaceutical Theranostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Radiopharmaceutical Theranostics Market is valued at US$ 337.53 Million in 2022, it is projected to reach US$ 667.40 Million by 2028.
As per our report Asia Pacific Radiopharmaceutical Theranostics Market, the market size is valued at US$ 337.53 Million in 2022, projecting it to reach US$ 667.40 Million by 2028. This translates to a CAGR of approximately 12.0% during the forecast period.
The Asia Pacific Radiopharmaceutical Theranostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Radiopharmaceutical Theranostics Market report:
The Asia Pacific Radiopharmaceutical Theranostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Radiopharmaceutical Theranostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Radiopharmaceutical Theranostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Radiopharmaceutical Theranostics Market
